NCT03664063View on ClinicalTrials.gov

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

January 1, 2019

Conditions
Lymphatic FilariasisYawsTrauma
Interventions
DRUG

Azithromycin

Treatment with Azithromycin single dose - weight based dosing max 2gm

DRUG

Albendazole

"Single dose of Albendazole weight based dosing~\- 400mg"

DRUG

Ivermectin

Ivermectin weight based dosing - max 21mg

DRUG

Diethylcarbamazine

Diethylcarbamazine weight based dosing - max 500mg

Trial Locations (1)

034

Lihir Medical Centre, Londolovit

Sponsors
All Listed Sponsors
lead

Lihir Medical Centre

OTHER